Bill Sponsor
House Bill 2149
117th Congress(2021-2022)
Protecting Americans with Pre-existing Conditions Act of 2021
Introduced
Introduced
Introduced in House on Mar 23, 2021
Overview
Text
Introduced
Mar 23, 2021
Latest Action
Mar 24, 2021
Origin Chamber
House
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
2149
Congress
117
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
Sponsorship by Party
Democrat
New Hampshire
Democrat
Connecticut
Democrat
Virginia
House Votes (0)
Senate Votes (0)
No House votes have been held for this bill.
Summary

Protecting Americans with Pre-Existing Conditions Act of 2021

This bill nullifies specified guidance and final rule provisions pertaining to Section 1332 waivers (also known as State Innovation Waivers or State Relief and Empowerment Waivers) issued by the Department of the Treasury and the Department of Health and Human Services. The provisions allow states to forego certain requirements of the Patient Protection and Affordable Care Act in order to implement experimental plans for health care coverage, as long as the resulting coverage meets certain statutory criteria.

The provisions, which supersede earlier guidance from 2015, alter agency interpretation of how states may satisfy the statutory criteria for waiver approval. For example, the provisions (1) redefine acceptable coverage under such waivers to include short-term, limited-duration insurance and association health plans; (2) allow the comprehensiveness and affordability of coverage under such waivers to be assessed based on projected availability, rather than enrollment; and (3) allow the level of coverage to be assessed based on the effects over the entire course of the waiver, rather than per year.

Text (1)
March 23, 2021
Actions (4)
03/24/2021
Referred to the Subcommittee on Health.
03/23/2021
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
03/23/2021
Referred to the Subcommittee on Health.
03/23/2021
Introduced in House
Public Record
Record Updated
Jan 11, 2023 1:48:04 PM